Exciting skincare to protect against blue light emitted by phones and devices

10 Sep 2018

Novel, dual-acting product revitalizes and protects skin against blue light and environmental aggressors around the clock.

Allergan has launched the new SkinMedica LUMIVIVE System, an innovative skincare product designed with two distinct formulas - one to shield skin from blue light and environmental aggressors during the day and another to recharge the skin's essential repair process at night.

Exciting skincare to protect against blue light emitted by phones and devices

During the day, LUMIVIVE offers full atmospheric protection and fights the signs of ageing for optimal skin health and vitality. At night, LUMIVIVE supports the skin's ability to repair itself overnight, restoring the appearance of a glowing, youthful complexion. Unlike any other product on the market, the innovative LUMIVIVETM System formulas work around the clock to support optimal skin vitality and radiance, and doesn't fade throughout the day or wash off, providing 24-hour protection and revitalization.

"Skin today is under attack from multiple invisible threats," said San Diego-based dermatologist Dr Sabrina Fabi. "Visible light, including blue light like that emitted by phones and devices, is particularly insidious, because it penetrates deeper than some forms of ultraviolet light, down into the third layer of the skin, accelerating the visible signs of ageing, such as dark spots, wrinkles, and saggy or loose skin. I am excited to help launch this innovative product that not only repairs skin and promotes a healthy-looking complexion, but is potent enough to protect us from the many environmental elements that can leave skin looking less than its best."

In clinical studies, completed in some of the most polluted cities in the world, LUMIVIVE improved the appearance of skin tone, evenness and restored stressed skin for a more luminous complexion. 85% of patients agreed that LUMIVIVE reduced the effects of environmental damage on their skin and kept their skin looking radiant throughout the day.

"People around the world, spend an average of 2 hours per day on social media, while the average American looks at their phone 47 times a day and spends about 10 hours a day in front of a screen," says Carrie Strom, Senior Vice President, US Medical Aesthetics at Allergan. "We know that blue light and pollution are all around us and can't be avoided. We felt it was important to address an unmet need by creating a system that not only protects the skin from environmental damage during the day, but also enhances the skin's ability to restore and repair skin during the sleep-repair cycle as well."

Read More

Related news

Moulds & Tooling: A European success story

Moulds & Tooling: A European success story

19 Sep 2018

While not quite an endangered species, the past fifteen years have not been easy ones for many European mould makers. Many, but not all, and IGS GeboJagema is a case in point – a case that shows the difference automation and focus can make. By Karen La...

Read more 
Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

18 Sep 2018

China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.

Read more 
Bio processing and manufacturing league table ranks US top and China bottom

Bio processing and manufacturing league table ranks US top and China bottom

3 Sep 2018

US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.

Read more 
Innovation hindered by regulators

Innovation "hindered by regulators"

27 Aug 2018

CPhI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.

Read more 
The 6-month FMD countdown - are you ready?

The 6-month FMD countdown - are you ready?

21 Aug 2018

With only 6 months left in which to become EU FMD-compliant, how can companies make the best use of their now limited options?

Read more 
Protecting the links between the UK and the EMA

Protecting the links between the UK and the EMA

14 Aug 2018

Now less than a year away from when the UK officially leaves the EU, the main goal remains the same - maintaining access to new drugs for patient health.

Read more 
Building contingency plans for an ambiguous post-Brexit market

Building contingency plans for an ambiguous post-Brexit market

31 Jul 2018

One company's positive approach to Brexit preparations, despite the lack of definition.

Read more 
Post-Brexit medicines - stuck in the UK?

Post-Brexit medicines - stuck in the UK?

30 Jul 2018

The EMA needs to provide more action and guidance to help UK pharmaceutical manufacturers, says Thomas Beck, senior vice president, quality management, Recipharm.

Read more 
Pharmacovigilance post-Brexit - simpler than previously thought?

Pharmacovigilance post-Brexit - simpler than previously thought?

24 Jul 2018

To meet new PV regulations, the industry has to face a "multitude of unknowns and an ever-moving target".

Read more 
South Korea's finished drug market growth driven by generics

South Korea's finished drug market growth driven by generics

16 Jul 2018

FDF launches at CPhI Korea as country set to become regional hub.

Read more